Franklin Resources’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.1M | Sell |
|
|||||
|
2025
Q2 | $88.4M | Buy |
|
|||||
|
2025
Q1 | $64.1M | Sell |
|
|||||
|
2024
Q4 | $83.1M | Sell |
|
|||||
|
2024
Q3 | $77.4M | Sell |
|
|||||
|
2024
Q2 | $111M | Buy |
|
|||||
|
2024
Q1 | $109M | Buy |
|
|||||
|
2023
Q4 | $102M | Buy |
|
|||||
|
2023
Q3 | $86.2M | Buy |
|
|||||
|
2023
Q2 | $68.7M | Buy |
|
|||||
|
2023
Q1 | $71.9M | Buy |
|
|||||
|
2022
Q4 | $82.9M | Sell |
|
|||||
|
2022
Q3 | $112M | Sell |
|
|||||
|
2022
Q2 | $115M | Buy |
|
|||||
|
2022
Q1 | $105M | Buy |
|
|||||
|
2021
Q4 | $82.1M | Sell |
|
|||||
|
2021
Q3 | $92.5M | Buy |
|
|||||
|
2021
Q2 | $93.7M | Buy |
|
|||||
|
2021
Q1 | $88M | Buy |
|
|||||
|
2020
Q4 | $85.8M | Sell |
|
|||||
|
2020
Q3 | $147M | Buy |
|
|||||
|
2020
Q2 | $189M | Sell |
|
|||||
|
2020
Q1 | $145M | Sell |
|
|||||
|
2019
Q4 | $213M | Buy |
|
|||||
|
2019
Q3 | $168M | Buy |
|
|||||
|
2019
Q2 | $139M | Sell |
|
|||||
|
2019
Q1 | $180M | Buy |
|
|||||
|
2018
Q4 | $145M | Buy |
|
|||||
|
2018
Q3 | $226M | Buy |
|
|||||
|
2018
Q2 | $179M | Sell |
|
|||||
|
2018
Q1 | $195M | Sell |
|
|||||
|
2017
Q4 | $238M | Sell |
|
|||||
|
2017
Q3 | $200M | Sell |
|
|||||
|
2017
Q2 | $155M | Buy |
|
|||||
|
2017
Q1 | $121M | Buy |
|
|||||
|
2016
Q4 | $93.3M | Buy |
|
|||||
|
2016
Q3 | $102M | Buy |
|
|||||
|
2016
Q2 | $70.1M | Buy |
|
|||||
|
2016
Q1 | $45.9M | Sell |
|
|||||
|
2015
Q4 | $67.9M | Sell |
|
|||||
|
2015
Q3 | $49.4M | Sell |
|
|||||
|
2015
Q2 | $64.7M | Hold |
|
|||||
|
2015
Q1 | $53.8M | Sell |
|
|||||
|
2014
Q4 | $43M | Buy |
|
|||||
|
2014
Q3 | $28.8M | Sell |
|
|||||
|
2014
Q2 | $32.7M | Hold |
|
|||||
|
2014
Q1 | $35.5M | Buy |
|
|||||
|
2013
Q4 | $19.6M | Buy |
|
|||||
|
2013
Q3 | $18.1M | Buy |
|
|||||
|
2013
Q2 | $19.4M | Buy |
|